Cargando…

Refined pancreatobiliary UroVysion criteria and an approach for further optimization

Pancreatobiliary strictures are a common source of false negatives for malignancy detection. UroVysion is more sensitive than any other method but remains underutilized because of conflicting sensitivities and specificities due to a lack of standardized cutoff criteria and confusion in interpreting...

Descripción completa

Detalles Bibliográficos
Autores principales: Mettman, Daniel, Saeed, Azhar, Shold, Janna, Laury, Raquele, Ly, Andrew, Khan, Irfan, Golem, Shivani, Olyaee, Mojtaba, O'Neil, Maura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419786/
https://www.ncbi.nlm.nih.gov/pubmed/34374212
http://dx.doi.org/10.1002/cam4.4043
_version_ 1783748824925208576
author Mettman, Daniel
Saeed, Azhar
Shold, Janna
Laury, Raquele
Ly, Andrew
Khan, Irfan
Golem, Shivani
Olyaee, Mojtaba
O'Neil, Maura
author_facet Mettman, Daniel
Saeed, Azhar
Shold, Janna
Laury, Raquele
Ly, Andrew
Khan, Irfan
Golem, Shivani
Olyaee, Mojtaba
O'Neil, Maura
author_sort Mettman, Daniel
collection PubMed
description Pancreatobiliary strictures are a common source of false negatives for malignancy detection. UroVysion is more sensitive than any other method but remains underutilized because of conflicting sensitivities and specificities due to a lack of standardized cutoff criteria and confusion in interpreting results in the context of primary sclerosing cholangitis. We set out to determine the sensitivities and specificities of UroVysion, brushing cytology, forceps biopsies, and fine needle aspiration (FNAs) for pancreatobiliary stricture malignancy detection. A retrospective review was performed of all biopsied pancreatobiliary strictures at our institution over 5 years. UroVysion was unquestionably the most sensitive method and all methods were highly specific. Sensitivity was highest while maintaining specificity when a malignant interpretation was limited to cases with 5+ cells with the same polysomic signal pattern and/or loss of one or both 9p21 signals. Only UroVysion detected the metastases and a neuroendocrine tumor. In reviewing and analyzing the signal patterns, we noticed trends according to location and diagnosis. Herein we describe our method for analyzing signal patterns and propose cutoff criteria based upon observations gleaned from such analysis.
format Online
Article
Text
id pubmed-8419786
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84197862021-09-08 Refined pancreatobiliary UroVysion criteria and an approach for further optimization Mettman, Daniel Saeed, Azhar Shold, Janna Laury, Raquele Ly, Andrew Khan, Irfan Golem, Shivani Olyaee, Mojtaba O'Neil, Maura Cancer Med Clinical Cancer Research Pancreatobiliary strictures are a common source of false negatives for malignancy detection. UroVysion is more sensitive than any other method but remains underutilized because of conflicting sensitivities and specificities due to a lack of standardized cutoff criteria and confusion in interpreting results in the context of primary sclerosing cholangitis. We set out to determine the sensitivities and specificities of UroVysion, brushing cytology, forceps biopsies, and fine needle aspiration (FNAs) for pancreatobiliary stricture malignancy detection. A retrospective review was performed of all biopsied pancreatobiliary strictures at our institution over 5 years. UroVysion was unquestionably the most sensitive method and all methods were highly specific. Sensitivity was highest while maintaining specificity when a malignant interpretation was limited to cases with 5+ cells with the same polysomic signal pattern and/or loss of one or both 9p21 signals. Only UroVysion detected the metastases and a neuroendocrine tumor. In reviewing and analyzing the signal patterns, we noticed trends according to location and diagnosis. Herein we describe our method for analyzing signal patterns and propose cutoff criteria based upon observations gleaned from such analysis. John Wiley and Sons Inc. 2021-08-10 /pmc/articles/PMC8419786/ /pubmed/34374212 http://dx.doi.org/10.1002/cam4.4043 Text en © 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Mettman, Daniel
Saeed, Azhar
Shold, Janna
Laury, Raquele
Ly, Andrew
Khan, Irfan
Golem, Shivani
Olyaee, Mojtaba
O'Neil, Maura
Refined pancreatobiliary UroVysion criteria and an approach for further optimization
title Refined pancreatobiliary UroVysion criteria and an approach for further optimization
title_full Refined pancreatobiliary UroVysion criteria and an approach for further optimization
title_fullStr Refined pancreatobiliary UroVysion criteria and an approach for further optimization
title_full_unstemmed Refined pancreatobiliary UroVysion criteria and an approach for further optimization
title_short Refined pancreatobiliary UroVysion criteria and an approach for further optimization
title_sort refined pancreatobiliary urovysion criteria and an approach for further optimization
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419786/
https://www.ncbi.nlm.nih.gov/pubmed/34374212
http://dx.doi.org/10.1002/cam4.4043
work_keys_str_mv AT mettmandaniel refinedpancreatobiliaryurovysioncriteriaandanapproachforfurtheroptimization
AT saeedazhar refinedpancreatobiliaryurovysioncriteriaandanapproachforfurtheroptimization
AT sholdjanna refinedpancreatobiliaryurovysioncriteriaandanapproachforfurtheroptimization
AT lauryraquele refinedpancreatobiliaryurovysioncriteriaandanapproachforfurtheroptimization
AT lyandrew refinedpancreatobiliaryurovysioncriteriaandanapproachforfurtheroptimization
AT khanirfan refinedpancreatobiliaryurovysioncriteriaandanapproachforfurtheroptimization
AT golemshivani refinedpancreatobiliaryurovysioncriteriaandanapproachforfurtheroptimization
AT olyaeemojtaba refinedpancreatobiliaryurovysioncriteriaandanapproachforfurtheroptimization
AT oneilmaura refinedpancreatobiliaryurovysioncriteriaandanapproachforfurtheroptimization